Skip to main content
. 2020 May 30;30(11):6139–6150. doi: 10.1007/s00330-020-06973-9

Table 4.

The result of univariate analysis

Variables Statistics OR (95% CI) p value
Sex, n (%)
  Male 258 (51.70) 1.0 (reference)
  Female 241 (48.30) 0.88 (0.62, 1.25) 0.485
Age, mean (SD), years 57.82 ± 14.19 1.04 (1.02, 1.05) < 0.0001
Age, n (%)
  < 60 year 248 (49.70) 1.0 (reference)
  ≥ 60 year 251 (50.30) 2.17 (1.52, 3.11) < 0.0001
BMI, mean (SD), kg/m2 22.68 ± 3.16 0.98 (0.93, 1.04) 0.594
BMI, n (%)
  < 23 kg/m2 248 (49.70) 1.0 (reference)
  ≥ 23 kg/m2 251 (50.30) 0.96 (0.67, 1.36) 0.813
Clinical type, n (%)
  Moderate 359 (71.94) 1.0 (reference)
  Severe 140 (28.06) 3.49 (2.26, 5.39) < 0.0001
Initial nucleic acid test, n (%)
  Negative 30 (6.01) 1.0 (reference)
  Positive 469 (93.99) 0.90 (0.43, 1.90) 0.789
Outcomes, n (%)
  Recovery 422 (84.57) 1.0 (reference)
  Therapy 69 (13.83) 3.34 (1.85, 6.04) < 0.0001
  Death 8 (1.60)
Fever, n (%)
  No 72 (14.43) 1.0 (reference)
  Yes 427 (85.57) 2.38 (1.42, 4.00) 0.001
Cough, n (%)
  No 113 (22.65) 1.0 (reference)
  Yes 386 (77.35) 1.28 (0.84, 1.95) 0.250
Myalgia or arthralgia, n (%)
  No 290 (58.12) 1.0 (reference)
  Yes 209 (41.88) 1.28 (0.90, 1.84) 0.173
Headache, n (%)
  No 486 (97.39) 1.0 (reference)
  Yes 13 (2.61) 0.98 (0.32, 2.96) 0.973
Nausea or vomiting, n (%)
  No 493 (98.80) 1.0 (reference)
  Yes 6 (1.20) 0.84 (0.17, 4.20) 0.831
Diarrhea, n (%)
  No 465 (93.19) 1.0 (reference)
  Yes 34 (6.81) 1.07 (0.53, 2.16) 0.849
Abdominal pain, n (%)
  No 494 (99.00) 1.0 (reference)
  Yes 5 (1.00) 0.981
Smoking history, n (%)
  No 466 (93.39) 1.0 (reference)
  Yes 33 (6.61) 1.74 (0.83, 3.68) 0.145
Cardiovascular disease, n (%)
  No 452 (90.58) 1.0 (reference)
  Yes 47 (9.42) 1.05 (0.57, 1.91) 0.884
Diabetes, n (%)
  No 444 (88.98) 1.0 (reference)
  Yes 55 (11.02) 1.69 (0.94, 3.03) 0.081
Hypertension, n (%)
  No 348 (69.74) 1.0 (reference)
  Yes 151 (30.26) 1.73 (1.17, 2.55) 0.006
COPD, n (%)
  No 497 (99.60) 1.0 (reference)
  Yes 2 (0.40) 0.84 (0.05, 13.52) 0.903
Chronic liver disease, n (%)
  No 488 (97.80) 1.0 (reference)
  Yes 11 (2.20) 1.01 (0.30, 3.35) 0.987
Chronic renal disease, n (%)
  No 492 (98.60) 1.0 (reference)
  Yes 7 (1.40) 0.63 (0.14, 2.83) 0.544
Malignant tumor, n (%)
  No 486 (97.39) 1.0 (reference)
  Yes 13 (2.61) 1.36 (0.44, 4.21) 0.597
WBC count, n (%)
  Decreased 46 (9.22) 1.0 (reference)
  Normal 422 (84.57) 1.72 (0.93, 3.19) 0.086
  Increased 31 (6.21) 2.98 (1.15, 7.75) 0.025
Lymphocyte count, n (%)
  Increased 8 (1.60) 1.0 (reference)
  Normal 288 (57.72) 2.24 (0.44, 11.27) 0.329
  Decreased 203 (40.68) 7.68 (1.51, 39.19) 0.014
CRP, n (%)
  Normal 243 (48.70) 1.0 (reference)
  Increased 256 (51.30) 4.58 (3.14, 6.69) < 0.0001

BMI body mass index, WBC white blood cell, CRP C-reactive protein, OR odds ratio, CI confidence interval, COPD chronic obstructive pulmonary disease